TLPH Q1 2025 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q1 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$27,000

Gross Profit

-$1M-4229.6% margin

Operating Income

-$3M-10800.0% margin

Net Income

-$3M-9603.7% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$196,000

Balance Sheet

Total Assets

$15M

Total Liabilities

$9M

Stockholders' Equity

$6M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27,000	$0	—
Gross Profit	-$1M	-$1M	+20.3%
Operating Income	-$3M	-$4M	+31.2%
Net Income	-$3M	-$4M	+34.4%